{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:25:47Z","timestamp":1793381147779,"version":"4.5.0"},"reference-count":88,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"unspecified","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,9,13]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Functional neurological disorder (FND) is a common cause of neurological disability with symptoms spanning motor, sensory and cognitive domains. While effective treatments exist, the impact of symptom chronicity on treatment outcomes is unclear. This systematic review and meta-analysis investigated whether longer symptom duration influences treatment outcomes across FND phenotypes: functional movement disorders, functional\/dissociative seizures (FDS) and mixed presentations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO and grey literature were systematically searched till 29 June 2024. Studies were included if they involved adult FND participants undergoing any intervention and evaluated symptom change, function and health-related quality of life (HrQoL). Studies were excluded with &lt;10 participants, missing symptom duration data or irrelevant outcomes. Two reviewers independently extracted data and assessed risk of bias. Meta-analyses used random effects models, subgroup analyses and univariate meta-regression to examine associations with symptom chronicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>63 studies met inclusion criteria; 27 studies (885 participants) were meta-analysed. Longer symptom duration modestly reduced improvements in motor symptoms (\u20133.24 points\/year, scale: 0\u2013100) and physical HrQoL (\u20131.2 points\/year, scale: 0\u2013100). Global improvements (mean Clinical Global Impression\u2013Change 2.43, 95%\u2009CI: 2.28 to 2.59, scale: 1\u20137) and mental HrQoL gains (mean Short Form\u2013Mental Component Summary +5.04 points, 95%\u2009CI: 1.67 to 8.41) were observed irrespective of chronicity. FDS frequency reduced after psychotherapy in eight of nine studies, even with prolonged symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Symptom chronicity modestly reduced motor and physical HrQoL improvements, but did not negate meaningful gains across a range of outcomes. Early diagnosis and treatment are critical for better outcomes, but remain beneficial in chronic stages.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001150","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:18Z","timestamp":1759731618000},"page":"e001150","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment outcomes in functional neurological disorder: a systematic review and meta-analysis exploring the influence of symptom chronicity"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-2246","authenticated-orcid":false,"given":"Sarah T","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T","family":"Thomas","sequence":"additional","affiliation":[{"name":"Centre for Evidence Based Medicine, University of Oxford, Oxford, UK"},{"name":"The University of Queensland Child Health Research Centre, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schembri","sequence":"additional","affiliation":[{"name":"Monash University Eastern Health Clinical School, Box Hill, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-7010","authenticated-orcid":false,"given":"Alexander C","family":"Lehn","sequence":"additional","affiliation":[{"name":"Neurology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia"},{"name":"The University of Queensland Princess Alexandra Hospital Clinical School, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David DG","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia"},{"name":"The Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"2025100523201138000_7.2.e001150.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2010.05.011"},{"key":"2025100523201138000_7.2.e001150.2","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1111\/ene.16003","article-title":"Functional neurological disorder: A common reason for a neurology inpatient referral","volume":"30","author":"Ramsay","year":"2023","journal-title":"Eur J Neurol"},{"key":"2025100523201138000_7.2.e001150.3","unstructured":"Stone J . Functional neurological disorder (FND) \u2013 a patient\u2019s guide to FND. Functional Neurological Disorder FND; 2009. Available: https:\/\/neurosymptoms.org\/en"},{"key":"2025100523201138000_7.2.e001150.4","unstructured":"Gill K . Consumer and carer experiences of fnd in australia: the silent crisis. Sydney The National Mental Health Commission; 1999."},{"key":"2025100523201138000_7.2.e001150.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.220640"},{"key":"2025100523201138000_7.2.e001150.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309255"},{"key":"2025100523201138000_7.2.e001150.7","doi-asserted-by":"crossref","unstructured":"Drane DL , Fani N , Hallett M , et al . A framework for understanding the pathophysiology of functional neurological disorder. CNS Spectr 2020;1\u20137. doi:10.1017\/S1092852920001789","DOI":"10.1017\/S1092852920001789"},{"key":"2025100523201138000_7.2.e001150.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305321"},{"key":"2025100523201138000_7.2.e001150.9","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/brain\/awz138","article-title":"The prognosis of functional limb weakness: a 14-year case-control study","volume":"142","author":"Gelauff","year":"2019","journal-title":"Brain (Bacau)"},{"key":"2025100523201138000_7.2.e001150.10","first-page":"169","article-title":"Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study","volume":"14","author":"Feinstein","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"2025100523201138000_7.2.e001150.11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21687"},{"key":"2025100523201138000_7.2.e001150.12","article-title":"Prognosis and outcome predictors in psychogenic nonepileptic seizures","volume":"2011","author":"Durrant","year":"2011","journal-title":"Epilepsy Res Treat"},{"key":"2025100523201138000_7.2.e001150.13","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32832dc169"},{"key":"2025100523201138000_7.2.e001150.14","doi-asserted-by":"crossref","first-page":"112201","DOI":"10.1016\/j.jpsychores.2025.112201","article-title":"Biopsychosocial prognostic indicators in Functional Neurological Disorder: A systematic review","volume":"195","author":"Sekine","year":"2025","journal-title":"J Psychosom Res"},{"key":"2025100523201138000_7.2.e001150.15","first-page":"284","article-title":"Engaging Patients in Decision-Making and Behavior Change to Promote Prevention","volume":"240","author":"Krist","year":"2017","journal-title":"Stud Health Technol Inform"},{"key":"2025100523201138000_7.2.e001150.16","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.656466","article-title":"A Service Evaluation of the Experiences of Patients With Functional Neurological Disorders Within the NHS","volume":"12","author":"O\u2019Keeffe","year":"2021","journal-title":"Front Neurol"},{"key":"2025100523201138000_7.2.e001150.17","doi-asserted-by":"crossref","first-page":"5547318","DOI":"10.1155\/2024\/5547318","article-title":"Delivering a Specialised Best Practice Service for People with Functional Neurological Disorder: An Australian Qualitative Descriptive Study","volume":"2024","author":"Pearce","year":"2024","journal-title":"Health & Social Care in the Community"},{"key":"2025100523201138000_7.2.e001150.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025100523201138000_7.2.e001150.19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid Synth"},{"key":"2025100523201138000_7.2.e001150.20","first-page":"4","volume-title":"Cochrane","volume":"6","author":"Higgins","year":"2023"},{"key":"2025100523201138000_7.2.e001150.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.02.009"},{"key":"2025100523201138000_7.2.e001150.22","doi-asserted-by":"publisher","DOI":"10.1159\/000446660"},{"key":"2025100523201138000_7.2.e001150.23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2013.09.018","article-title":"Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial","volume":"20","author":"Kompoliti","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"2025100523201138000_7.2.e001150.24","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-1246"},{"key":"2025100523201138000_7.2.e001150.25","doi-asserted-by":"publisher","DOI":"10.1159\/000049348"},{"key":"2025100523201138000_7.2.e001150.26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320071"},{"key":"2025100523201138000_7.2.e001150.27","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00338","article-title":"Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect?","volume":"8","author":"Garcin","year":"2017","journal-title":"Front Neurol"},{"key":"2025100523201138000_7.2.e001150.28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27727"},{"key":"2025100523201138000_7.2.e001150.29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314408"},{"key":"2025100523201138000_7.2.e001150.30","doi-asserted-by":"publisher","DOI":"10.1076\/iceh.51.1.29.14067"},{"key":"2025100523201138000_7.2.e001150.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037198","article-title":"Trial Of Neurostimulation In Conversion Symptoms (TONICS): a feasibility randomised controlled trial of transcranial magnetic stimulation for functional limb weakness","volume":"10","author":"Pick","year":"2020","journal-title":"BMJ Open"},{"key":"2025100523201138000_7.2.e001150.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00135-2"},{"key":"2025100523201138000_7.2.e001150.33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.11.018","article-title":"Multidisciplinary inpatient rehabilitation for Functional Movement Disorders: A prospective study with long term follow up","volume":"82","author":"Hebert","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"2025100523201138000_7.2.e001150.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7631-1"},{"key":"2025100523201138000_7.2.e001150.35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.parkreldis.2014.02.029","article-title":"Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor","volume":"20","author":"Espay","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"2025100523201138000_7.2.e001150.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7495-4"},{"key":"2025100523201138000_7.2.e001150.37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.parkreldis.2011.10.011","article-title":"Functional movement disorders: Successful treatment with a physical therapy rehabilitation protocol","volume":"18","author":"Czarnecki","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"key":"2025100523201138000_7.2.e001150.38","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1007\/s00415-022-11230-8","article-title":"Improvement in motor symptoms, physical fatigue, and self-rated change perception in functional motor disorders: a prospective cohort study of a 12-week telemedicine program","volume":"269","author":"Gandolfi","year":"2022","journal-title":"J Neurol"},{"key":"2025100523201138000_7.2.e001150.39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mdc3.13268","article-title":"Evaluation of Individualized Multi-Disciplinary Inpatient Treatment for Functional Movement Disorders","volume":"8","author":"Schmidt","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"2025100523201138000_7.2.e001150.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.05.004"},{"key":"2025100523201138000_7.2.e001150.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-5215.2012.00668.x"},{"key":"2025100523201138000_7.2.e001150.42","doi-asserted-by":"publisher","DOI":"10.3233\/NRE-201617"},{"key":"2025100523201138000_7.2.e001150.43","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1206"},{"key":"2025100523201138000_7.2.e001150.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(96)90159-8"},{"key":"2025100523201138000_7.2.e001150.45","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00415-020-09874-5","article-title":"Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD)","volume":"267","author":"Petrochilos","year":"2020","journal-title":"J Neurol"},{"key":"2025100523201138000_7.2.e001150.46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1176\/jnp.23.2.jnp141","article-title":"Transcutaneous Electrical Stimulation (TENS) for Psychogenic Movement Disorders","volume":"23","author":"Ferrara","year":"2011","journal-title":"JNP"},{"key":"2025100523201138000_7.2.e001150.47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.neuropsych.19030067","article-title":"Outpatient CBT for Motor Functional Neurological Disorder and Other Neuropsychiatric Conditions: A Retrospective Case Comparison","volume":"32","author":"O\u2019Connell","year":"2020","journal-title":"JNP"},{"key":"2025100523201138000_7.2.e001150.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2018.05.011"},{"key":"2025100523201138000_7.2.e001150.49","first-page":"e1787","article-title":"Clinical and neural responses to cognitive behavioral therapy for functional tremor","volume":"93","author":"Espay","year":"2019","journal-title":"Neurology (ECronicon)"},{"key":"2025100523201138000_7.2.e001150.50","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304062"},{"key":"2025100523201138000_7.2.e001150.51","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00415-023-12111-4","article-title":"Routine outcomes and evaluation of an 8-week outpatient multidisciplinary rehabilitative therapy program for functional neurological disorder","volume":"271","author":"Guy","year":"2024","journal-title":"J Neurol"},{"key":"2025100523201138000_7.2.e001150.52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PHM.0000000000002303","article-title":"Inpatient Rehabilitation for Acute Presentations of Motor Functional Neurological Disorder: A Retrospective Cohort Study","volume":"103","author":"Polich","year":"2024","journal-title":"Am J Phys Med Rehabil"},{"key":"2025100523201138000_7.2.e001150.53","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/mdc3.13844","article-title":"Outpatient Motor Retraining for Functional Movement Disorder: Predictors of a Favorable Short-Term Response","volume":"10","author":"Callister","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"2025100523201138000_7.2.e001150.54","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305716"},{"key":"2025100523201138000_7.2.e001150.55","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.19030068"},{"key":"2025100523201138000_7.2.e001150.56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mdc3.14007","article-title":"Factors Influencing Triage to Rehabilitation in Functional Movement Disorder","volume":"11","author":"Gilmour","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"2025100523201138000_7.2.e001150.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2016.08.010"},{"key":"2025100523201138000_7.2.e001150.58","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12481"},{"key":"2025100523201138000_7.2.e001150.59","doi-asserted-by":"crossref","first-page":"3000605211067902","DOI":"10.1177\/03000605211067902","article-title":"Estimating the minimal clinically important difference for the Physical Component Summary of the Short Form 36 for patients with stroke","volume":"49","author":"Fu","year":"2021","journal-title":"J Int Med Res"},{"key":"2025100523201138000_7.2.e001150.60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2215-0366(20)30128-0","article-title":"Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial","volume":"7","author":"Goldstein","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2025100523201138000_7.2.e001150.61","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1212\/WNL.0b013e3181e39658","article-title":"Cognitive-behavioral therapy for psychogenic nonepileptic seizures","volume":"74","author":"Goldstein","year":"2010","journal-title":"Neurology (ECronicon)"},{"key":"2025100523201138000_7.2.e001150.62","first-page":"27","article-title":"Pilot Data from the Evaluation of an Integrative Body Psychotherapy Program for Patients with Psychogenic Non-Epileptic Seizures","volume":"71","author":"Senf-Beckenbach","year":"2021","journal-title":"Psychother Psychosom Med Psychol"},{"key":"2025100523201138000_7.2.e001150.63","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamapsychiatry.2014.817","article-title":"Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial","volume":"71","author":"LaFrance","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"2025100523201138000_7.2.e001150.64","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/epi.14728","article-title":"Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures","volume":"60","author":"Tolchin","year":"2019","journal-title":"Epilepsia"},{"key":"2025100523201138000_7.2.e001150.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106534"},{"key":"2025100523201138000_7.2.e001150.66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10309-014-0414-y","article-title":"Psychogenic non-epileptic seizures: long-term experience with an inpatient treatment concept","volume":"28","author":"Miersch","year":"2015","journal-title":"Zeitschrift Fur Epileptologie"},{"key":"2025100523201138000_7.2.e001150.67","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.60.06.018"},{"key":"2025100523201138000_7.2.e001150.68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2015.12.016","article-title":"Predictors of 6-month and 3-year outcomes after psychological intervention for psychogenic non epileptic seizures","volume":"36","author":"Duncan","year":"2016","journal-title":"Seizure"},{"key":"2025100523201138000_7.2.e001150.69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02656.x"},{"key":"2025100523201138000_7.2.e001150.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108277"},{"key":"2025100523201138000_7.2.e001150.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.06.008"},{"key":"2025100523201138000_7.2.e001150.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.05.007"},{"key":"2025100523201138000_7.2.e001150.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.02.016"},{"key":"2025100523201138000_7.2.e001150.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.10.019"},{"key":"2025100523201138000_7.2.e001150.75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yebeh.2014.03.012","article-title":"CBT-based group therapy intervention for nonepileptic attacks and other functional neurological symptoms: A pilot study","volume":"34","author":"Conwill","year":"2014","journal-title":"Epilepsy & Behavior"},{"key":"2025100523201138000_7.2.e001150.76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yebeh.2017.02.014","article-title":"Evaluation of a pilot innovative cognitive-behavioral therapy-based psychoeducation group treatment for functional non-epileptic attacks","volume":"70","author":"Cope","year":"2017","journal-title":"Epilepsy & Behavior"},{"key":"2025100523201138000_7.2.e001150.77","first-page":"S52","article-title":"Psychogenic non-epileptic seizures, prospective clinical experience: diagnosis, clinical features, risk factors, psychiatric comorbidity, treatment outcome","volume":"9 Suppl 1","author":"Hovorka","year":"2007","journal-title":"Epileptic Disord"},{"key":"2025100523201138000_7.2.e001150.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2008.02.006"},{"key":"2025100523201138000_7.2.e001150.79","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.22.4.401"},{"key":"2025100523201138000_7.2.e001150.80","doi-asserted-by":"crossref","first-page":"109745","DOI":"10.1016\/j.yebeh.2024.109745","article-title":"Breathing control training for functional seizures: A multi-site, open-label pilot study","volume":"154","author":"Duncan","year":"2024","journal-title":"Epilepsy Behav"},{"key":"2025100523201138000_7.2.e001150.81","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1007\/s00415-021-10797-y","article-title":"Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder","volume":"268","author":"Gutkin","year":"2021","journal-title":"J Neurol"},{"key":"2025100523201138000_7.2.e001150.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2007.06.013"},{"key":"2025100523201138000_7.2.e001150.83","doi-asserted-by":"crossref","first-page":"109745","DOI":"10.1016\/j.yebeh.2024.109745","article-title":"Breathing control training for functional seizures: A multi-site, open-label pilot study","volume":"154","author":"Duncan","year":"2024","journal-title":"Epilepsy & Behavior"},{"key":"2025100523201138000_7.2.e001150.84","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1017\/S1352465817000807","article-title":"Changes in Emotion Processing following Brief Augmented Psychodynamic Interpersonal Therapy for Functional Neurological Symptoms","volume":"46","author":"Williams","year":"2018","journal-title":"Behav Cogn Psychother"},{"key":"2025100523201138000_7.2.e001150.85","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322180"},{"key":"2025100523201138000_7.2.e001150.86","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102623","article-title":"Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda","volume":"30","author":"Perez","year":"2021","journal-title":"Neuroimage Clin"},{"key":"2025100523201138000_7.2.e001150.87","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-013-3399-2"},{"key":"2025100523201138000_7.2.e001150.88","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3283633953"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:24Z","timestamp":1759731624000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,5]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001150"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001150","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}